Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,456 total articles
Micron has re-rated into a trillion-dollar AI infrastructure proxy after a parabolic run and a flurry of bullish analyst notes. The stock is priced for perfection: market cap ~$1.23 trillion, trailing P/E ~51x, and sold-out HBM capacity. This trade idea is a short-term, earnings-driven long to capture the run-up into the June 24 fiscal Q3 report wh…
Sony is trading near 52-week lows while executing a multi-year shift toward recurring, high-margin entertainment assets. Recent strategic moves — including a ~$4B music catalog purchase and continued investment in film and subscription services — point to faster royalty and services revenue growth. Technicals are weak and memory-driven console head…
Fiserv plunged on an abrupt CEO exit and activist pressure, but the business still generates roughly $4.1B of free cash flow, trades at ~8x earnings and ~6.4x EV/EBITDA, and is now trading near its 52-week low. This is a tactical long that bets on stabilization of leadership and execution of the turnaround plan over the next 45 trading days.
Palantir has been consolidating near its 52-week low while fundamentals remain strong. This trade treats the sideways action as the technical setup for a mid-term long, not a bet on reaccelerating AI multiple expansion. Entry $135.00, stop $121.00, target $170.00 — sized for a high-risk, high-reward swing lasting roughly 45 trading days.
Microsoft's scale, cloud footprint, and high-margin software flywheel position it to compound earnings meaningfully as AI monetization accelerates. The market is pricing growth conservatively — we initiate a long trade at $400.00 with a $480 target and $360 stop over a 180-trading-day horizon, balancing upside from multiple catalysts against execut…
Energy Transfer (ET) offers a mix of high current income and project-driven volume growth. At ~$18.90 the market is pricing a moderate recovery while leaving upside if new projects ramp and FCF remains resilient. This trade targets a re-rating and distribution sustainability over a 180 trading day horizon with explicit entry, stop and target levels…
Marvell has moved from a niche infrastructure silicon vendor to a de facto supplier for hyperscalers' custom chip and optical interconnect programs. The company carries premium multiples today, but its balance sheet, recurring design wins, and exposure to AI data-center buildouts make a measured long trade attractive. Entry $305, stop $285, target …
PDD is trading at a single-digit forward P/E with meaningful cash generation and a sub-$120B market cap. We propose a tactical long using a slightly below-market entry, a tight stop, and a mid-term target that assumes a partial rerating as growth stabilizes and Temu margins improve.
Microsoft’s AI stack is expanding into enterprise workflows with durable monetization levers. The stock still appears to discount material upside from AI-driven revenue mix shifts. I lay out an entry at $420.00, a stop at $390.00 and a target at $490.00, with milestones and risks investors should monitor.
Western Midstream (WES) offers a compelling income trade: an 8%+ distribution, $1.34B of free cash flow and an EV/EBITDA of ~11.1. Technicals are neutral, fundamentals show healthy coverage and scale, and near-term catalysts (MLP flows, produced-water growth, steady gas volumes) support upside. Recommendation: add at $44.00, stop $40.50, target $49…
JOYY Inc. is showing the sort of execution that can force a re-rating: rising user engagement on BIGO assets, improving technicals and a high 6.2% yield make the stock attractive at a $3.47B market cap. This is a mid-term swing trade - enter near $68.90, target $85.00, stop $62.00 - sized conservatively to respect execution and regulatory risks.
TripAdvisor is cheap on several operating multiples, free cash flow is meaningful relative to market cap, and the announced $700M sale of TheFork to American Express materially reshapes capital-allocation optionality. With an activist pushing for strategic moves and technicals showing momentum, a disciplined long trade captures upside toward the st…
Red Cat’s Variant 7 (V7) naval autonomy platform is now in full-rate production via Blue Ops. The move materially de-risks delivery and scale for the company’s maritime ambitions and could unlock defense contract momentum. This is a mid-term swing trade idea: a disciplined long with a defined entry at $11.97, stop at $9.50 and target at $18.78 over…
Duolingo has been punished for guiding toward slower near-term monetization while prioritizing user growth. With a market cap near $5.9B, free cash flow of $416M, and trackable user momentum, the current setup offers an asymmetric long: limited valuation downside relative to the potential upside when monetization and AI-driven engagement reaccelera…
Vestas has pushed a lot of operational heavy lifting into 2025-2026 and the market is starting to recognize a steadier, higher-quality earnings profile. With a $26.3B market cap, a P/E ~25.5 and a tidy annual dividend, the stock offers asymmetric upside toward prior highs if orders and service momentum continue. This trade idea lays out an actionab…
GATX is a capital-efficient rail-asset lessor trading at ~18.6x earnings with a market cap of roughly $6.25B and free cash flow of $719M. Strong leasing fundamentals, a disciplined fleet remarketing market, and recent strategic transactions support a long trade. Enter near $176, stop at $156, and target $225 over a long-term (180 trading days) hori…
ASML is trading at a premium today ($1,892.24) but remains the only game in town for next-generation lithography. Strong secular demand for AI chips, recent buybacks, and bullish technicals support a long trade. Enter on small weakness, run the position through the next major order cycles, and protect capital with a conservative stop.
CME Group is uniquely exposed to sustained volatility and higher rates that are lifting futures volumes and fees. With a $96B market cap, 4.2% dividend yield and strong free cash flow, CME looks like a reasonable mid-term long while macro volatility persists. This trade lays out a specific entry at $266.07, a stop at $255.00 and a 45-trading-day ta…
The Charles Schwab Corporation just printed an all-time high in free cash flow, giving the firm flexibility to buy back stock, support dividends, and invest in growth. With reasonable valuation metrics (EV/EBITDA ~8.7, P/E ~17.5) and technicals near the 50-day average, this is a tactical long for investors who want income-plus-growth exposure to th…
Pernod Ricard offers a durable earnings base, pricing power in premium spirits, and a balance sheet able to support buybacks and acquisitions. Valuation looks attractive relative to the company's franchise strength. We lay out an actionable long-term trade with entry, stop and target, plus catalysts and risks to watch.
Ameriprise combines sticky advisory revenues with a capital-light asset management arm and sizable free cash flow. Trading around $460 with a market cap near $41.3B, the stock is inexpensive on P/E (~10.6) and P/FCF (~5.96) metrics while delivering a rare ROE of ~62.7%. We present a long trade plan with an entry at $460, stop at $420 and a target a…
Zimmer Biomet is a steady cash generator in orthopedics with a market cap of roughly $17.1B, an FCF yield north of 6%, and room to rerate if procedure volumes and product adoption in high-growth niches (orthobiologics, foot & ankle, wound care) accelerate. This trade favors a controlled long with a 45-trading-day horizon: entry near $88.26, stop at…
IBM is not a breakout growth story, but it is a cash-generative, high-ROE technology services firm positioned to benefit from enterprises shifting AI to on-prem and hybrid cloud architectures. At roughly $252.5B market cap, IBM's earnings power, dividend yield and nascent quantum/AI catalysts make it a reasonable candidate for multiple expansion. T…
Marubeni (MARUY) looks set for a mid-term re-rating after investor-day takeaways: clearer capital-return discipline across trading-house peers, a material offtake and equity tie-up in low-carbon ammonia with Exxon (05/08/2025), and renewed institutional demand from Berkshire-linked allocations (04/23/2026). At a $52.6B market cap and a P/E of ~14, …
Recent ASCO data and multiple positive signals across Immatics' PRAME programs (anzu-cel/IMA203 and next-gen assets) argue that PRAME is becoming a platform rather than a single therapy. With a market cap of $1.27B, a $125M equity raise behind it, and a Phase 3 program on track for BLA submission in H1 2027, Immatics presents a high-reward long tra…
